WHO ICTRP trial
Expression and role of HEG1 in non-small cell lung cancer
ChiCTR2000035343 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000035343 |
|---|---|
| Public title | Expression and role of HEG1 in non-small cell lung cancer |
| Scientific title | Expression and role of HEG1 in non-small cell lung cancer |
| Primary sponsor | Qingdao Municipal Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | 0 |
| Countries | China |
| Conditions | lung cancer |
| Interventions | Gold Standard:Pathology;Index test:HEG1 concentration |
| Registration date | Aug 9, 2020 |
| Target size | Target condition:80;Difficult condition:80 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: